<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01236846</url>
  </required_header>
  <id_info>
    <org_study_id>ABT-1236-RV</org_study_id>
    <nct_id>NCT01236846</nct_id>
  </id_info>
  <brief_title>Vitamin D Receptor Polymorphisms and Efficacy of Vitamin D-Fortified Yogurt Drink in Patients With Type 2 Diabetes</brief_title>
  <official_title>Determination of VDR Single Nucleotide Polymorphisms (SNPs ) and Their Rols in Efficacy of Vitamin D-fortified Yogurt Drink on the Metabolic-, Inflammatory - and Oxidative Stress Parameters in Type 2 Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tirang R. Neyestani</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Nutrition and Food Technology Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study is a 12-week Double blind,controlled experiments designed to examine the possible
      effects of vitamin D receptor gene polymorphisms on the metabolic, inflammatory and oxidative
      stress markers in type 2 diabetic patients to vitamin D-fortified yogurt drink intake.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a 12-week randomized controlled trial ( double-blind study), based on data on serum
      25(OH)D changes from other studies (35), to achieve 1 standard deviation difference in
      circulating 25(OH)D with two-sided alpha of 0.05 and a beta of 0.2 after a 12-week
      intervention period, the sample size was calculated 40 individuals per treatment group.
      Considering 3 polymorphic variant groups and one control group which receives plain yogurt
      drink, 160 subjects are needed. Allowing for 10% attrition over 12 weeks of intervention, a
      total of 180 subjects are required. In treatment groups, all patients receive 500 ml per day
      of low-fat (1%) Yogurt Drink fortified with approximately 500IU of vitamin D3 . Control group
      receives 500 ml per day of plain (unfortified) Yogurt Drink. Metabolic, inflammatory and
      oxidative stress markers are evaluated at the beginning and in the end of the interventional
      period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum 25-hydroxyvitamin D</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress markers</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profiles</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>3 Months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Plain Yogurt Drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily intake of unfortified yogurt drink(500 ml) for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VDR Genotype (aa)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily intake of yogurt drink fortified (500 ml) with 1000IU vitamin D for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VDR Genotype (AA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily intake of yogurt drink fortified (500 ml) with 1000 IU vitamin D for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VDR genotype (Aa)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily intake of yogurt drink fortified (500 ml) with 1000IU vitamin D for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fortified Yogurt Drink</intervention_name>
    <description>Daily intake of yogurt drink fortified (500 ml) with 1000IU vitamin D for 12 weeks</description>
    <arm_group_label>VDR Genotype (aa)</arm_group_label>
    <arm_group_label>VDR Genotype (AA)</arm_group_label>
    <arm_group_label>VDR genotype (Aa)</arm_group_label>
    <other_name>FYD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plain Yogurt Drink</intervention_name>
    <description>Daily intake of unfortified yogurt drink(500 ml)for 12 weeks</description>
    <arm_group_label>Plain Yogurt Drink</arm_group_label>
    <other_name>PYD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  Informed consent

          -  BMI between 25 to 35 kg/m2

          -  Age: 30-45 years old

          -  Willingness to maintain current body weight for the duration of the study

          -  Willingness to maintain baseline lifestyle activities and routines for the duration of
             the study

          -  Willingness to avoid the use of all over-the-counter or prescription vitamins, dietary
             supplements, and herbal products during the study

        Exclusion Criteria:

          -  History of cardiovascular , Gastrointestinal , Renal disease and any other
             endocrinological disorders

          -  Subjects receiving vitamin D or omega-3 supplement

          -  Pregnancy , or lactation within the study period

          -  Treatment with insulin

          -  Treatment for weight reduction

          -  Treatment for reducing serum lipids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tirang R. Neyestani, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>National Nutrition &amp; Food technology Research institute, P.O. Box 19395-4741</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abolghasem Djazayeri, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sakineh Shab-Bidar, M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Nutrition and Food Technology Research Institute</name>
      <address>
        <city>Tehran</city>
        <zip>19395-4741</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Nutrition and Food Technology Research Institute</name>
      <address>
        <city>Tehran</city>
        <zip>1981619573</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tirang Neyestani</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <last_update_submitted>April 25, 2012</last_update_submitted>
  <last_update_submitted_qc>April 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>National Nutrition and Food Technology Institute</investigator_affiliation>
    <investigator_full_name>Tirang R. Neyestani</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>Vitamin D fortification</keyword>
  <keyword>Yogurt Drink</keyword>
  <keyword>Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

